ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for GENETIX BIOTHERAPEUTICS, INC. · Biotechnology and pharmaceutical company.

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 14, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.